Haemonetics Ownership | Who Owns Haemonetics?


OverviewForecastRevenueFinancialsChartTranscripts

Haemonetics Ownership Summary


Haemonetics is owned by 108.45% institutional investors, 0.89% insiders. Capital research global investors is the largest institutional shareholder, holding 13.62% of HAE shares. American Funds SMALLCAP World A is the top mutual fund, with 5.01% of its assets in Haemonetics shares.

HAE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHaemonetics108.45%0.89%-9.34%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryMedical Instruments & Supplies Stocks57.74%11.38%30.88%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital research global investors6.92M13.62%$572.10M
Blackrock5.96M11.73%$493.00M
Vanguard group5.14M10.12%$425.29M
Wellington management group llp3.84M7.56%$317.51M
Neuberger berman group3.83M7.55%$317.18M
State street1.85M3.64%$153.09M
T. rowe price investment management1.64M3.23%$135.92M
Franklin resources1.42M2.81%$117.86M
Royce & associates lp1.18M2.32%$97.59M
Geode capital management1.17M2.31%$97.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sg capital management181.83K2.54%$15.04M
Riverwater partners15.73K0.96%$1.30M
Royce & associates lp1.18M0.91%$97.59M
Aristotle capital boston303.37K0.84%$25.10M
Oberweis asset management inc/165.29K0.84%$13.67M
Intrinsic edge capital management110.00K0.82%$9.10M
Heartland advisors172.70K0.80%$14.29M
Mizuho markets americas363.59K0.72%$30.08M
Keene & associates9.88K0.67%$817.04K
Neo ivy capital management40.78K0.66%$3.37M

Top Buyers

HolderShares% AssetsChange
Thrivent financial for lutherans849.35K0.14%836.62K
Norges bank484.71K0.01%484.71K
Goldman sachs group617.43K0.01%456.29K
T. rowe price investment management1.64M0.09%424.73K
Mizuho markets americas363.59K0.72%363.59K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp3.84M0.06%-433.00K
Vanguard group5.14M0.01%-256.63K
Point72 asset management---219.02K
Price t rowe associates inc /md/348.06K0.00%-214.39K
Arrowstreet capital, limited partnership---110.11K

New Positions

HolderShares% AssetsChangeValue
Norges bank484.71K0.01%484.71K$40.10M
Mizuho markets americas363.59K0.72%363.59K$30.08M
Brown advisory342.14K0.04%342.14K$28.31M
Sg capital management181.83K2.54%181.83K$15.04M
Two sigma investments, lp109.70K0.02%109.70K$9.08M

Sold Out

HolderChange
Rfp financial group-1.00
Tfc financial management-1.00
Tfo-tdc-2.00
Visionpoint advisory group-3.00
Concourse financial group securities-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024317-2.46%55,196,535-1.16%1080.90%152-9.52%1114.72%
Jun 30, 20243216.29%55,777,43810.02%1091.10%16413.89%106-7.83%
Mar 31, 2024302-1.63%50,699,7740.26%991.01%14414.29%115-6.50%
Dec 31, 20233071.66%50,568,886-0.64%990.99%126-5.97%123-
Sep 30, 2023302-0.66%50,893,3230.68%1001.00%134-12311.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A2.57M5.01%-413.07K
Neuberger Berman Genesis Inv2.03M3.96%26.87K
iShares Core S&P Mid-Cap ETF1.64M3.27%3.25K
Vanguard Total Stock Mkt Idx Inv1.60M3.17%-7.39K
iShares Russell 2000 ETF1.39M2.77%-2.91K
Vanguard Small Cap Index1.28M2.55%2.50K
Vanguard Explorer Inv1.15M2.24%66.61K
Capital Group AMCAP Composite1.09M2.13%-1.96M
VA CollegeAmerica Amcap 529A1.09M2.13%-1.96M
T. Rowe Price Small-Cap Stock904.85K1.77%36.20K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 26, 2024Strong Stewart W President, Global HospitalSell$393.04K
Jul 12, 2024Lingamneni Anila EVP, Chief Technology OfficerSell$7.11K
Jul 11, 2024Lingamneni Anila EVP, Chief Technology OfficerSell$192.24K
May 29, 2024Basil Michelle L EVP and General CounselSell$362.61K
May 29, 2024Basil Michelle L EVP and General CounselSell$781.60K

Insider Transactions Trends


DateBuySell
2024 Q3-3
2024 Q2-12
2024 Q1--
2023 Q4--
2023 Q3-4

HAE Ownership FAQ


Who Owns Haemonetics?

Haemonetics shareholders are primarily institutional investors at 108.45%, followed by 0.89% insiders and -9.34% retail investors. The average institutional ownership in Haemonetics's industry, Medical Instruments & Supplies Stocks, is 57.74%, which Haemonetics exceeds.

Who owns the most shares of Haemonetics?

Haemonetics’s largest shareholders are Capital research global investors (6.92M shares, 13.62%), Blackrock (5.96M shares, 11.73%), and Vanguard group (5.14M shares, 10.12%). Together, they hold 35.47% of Haemonetics’s total shares outstanding.

Does Blackrock own Haemonetics?

Yes, BlackRock owns 11.73% of Haemonetics, totaling 5.96M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 493M$. In the last quarter, BlackRock decreased its holdings by -25.268K shares, a -0.42% change.

Who is Haemonetics’s biggest shareholder by percentage of total assets invested?

Sg capital management is Haemonetics’s biggest shareholder by percentage of total assets invested, with 2.54% of its assets in 181.83K Haemonetics shares, valued at 15.04M$.

Who is the top mutual fund holder of Haemonetics shares?

American Funds SMALLCAP World A is the top mutual fund holder of Haemonetics shares, with 5.01% of its total shares outstanding invested in 2.57M Haemonetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools